<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82311</article-id><article-id pub-id-type="doi">10.7554/eLife.82311</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Intermittent fasting induces rapid hepatocyte proliferation to restore the hepatostat in the mouse liver</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-89749"><name><surname>Sarkar</surname><given-names>Abby</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6101-1721</contrib-id><email>abby.sarkar@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288469"><name><surname>Jin</surname><given-names>Yinhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288470"><name><surname>DeFelice</surname><given-names>Brian C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-299029"><name><surname>Logan</surname><given-names>Catriona Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-288472"><name><surname>Yang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288473"><name><surname>Anbarchian</surname><given-names>Teni</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288474"><name><surname>Wu</surname><given-names>Peng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6565-0002</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122144"><name><surname>Morri</surname><given-names>Maurizio</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163621"><name><surname>Neff</surname><given-names>Norma F</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288475"><name><surname>Nguyen</surname><given-names>Huy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288476"><name><surname>Rulifson</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189746"><name><surname>Fish</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299040"><name><surname>Kaye</surname><given-names>Avi Gurion</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-288478"><name><surname>Martínez Jaimes</surname><given-names>Azalia M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-13761"><name><surname>Nusse</surname><given-names>Roel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7082-3748</contrib-id><email>rnusse@stanford.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute, Department of Developmental Biology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Chan-Zuckerberg Biohub</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford Center for Genomics &amp; Personalized Medicine, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Department of Pediatrics, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Department of Neurology and Neurological Sciences, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mistry</surname><given-names>Pramod</given-names></name><role>Reviewing Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>31</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82311</elocation-id><history><date date-type="received" iso-8601-date="2022-07-30"><day>30</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-12-09"><day>09</day><month>12</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-10-16"><day>16</day><month>10</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.10.16.464650"/></event></pub-history><permissions><copyright-statement>© 2023, Sarkar et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Sarkar et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82311-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82311-figures-v1.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" xlink:href="10.7554/eLife.85606" id="ra1"/><abstract><p>Nutrient availability fluctuates in most natural populations, forcing organisms to undergo periods of fasting and re-feeding. It is unknown how dietary changes influence liver homeostasis. Here, we show that a switch from ad libitum feeding to intermittent fasting (IF) promotes rapid hepatocyte proliferation. Mechanistically, IF-induced hepatocyte proliferation is driven by the combined action of systemic FGF15 and localized WNT signaling. Hepatocyte proliferation during periods of fasting and re-feeding re-establishes a constant liver-to-body mass ratio, thus maintaining the hepatostat. This study provides the first example of dietary influence on adult hepatocyte proliferation and challenges the widely held view that liver tissue is mostly quiescent unless chemically or mechanically injured.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>liver</kwd><kwd>regeneration</kwd><kwd>intermittent fasting</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Nusse</surname><given-names>Roel</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Stinehart Reed Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Nusse</surname><given-names>Roel</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Cancer Research Program</institution></institution-wrap></funding-source><award-id>W81XWH-17-1-0245</award-id><principal-award-recipient><name><surname>Sarkar</surname><given-names>Abby</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001021</institution-id><institution>Damon Runyon Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>DRSG-28P-19</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Peng</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 CA124435</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Hepatocytes proliferate to maintain a constant liver-to-body mass ratio during intermittent fasting.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Periods of fasting and re-feeding induce profound tissue remodeling and regeneration in several tissues including the intestine (<xref ref-type="bibr" rid="bib23">O’Brien et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Yilmaz et al., 2012</xref>), the muscle (<xref ref-type="bibr" rid="bib2">Cerletti et al., 2012</xref>), and blood (<xref ref-type="bibr" rid="bib1">Brandhorst et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Chen et al., 2003</xref>; <xref ref-type="bibr" rid="bib6">Ertl et al., 2008</xref>). These tissue changes are thought to be mediated through diet-induced growth factor signaling, including both local (paracrine) and systemic (endocrine) signals that influence cell biology and function (<xref ref-type="bibr" rid="bib21">Mihaylova et al., 2014</xref>). The impact of fasting and re-feeding on liver tissue homeostasis is unknown.</p><p>In contrast to other organs, the liver maintains a constant ratio with body weight to preserve homeostasis—this is termed the hepatostat (<xref ref-type="bibr" rid="bib19">Michalopoulos, 2021</xref>). For example, when injured, the liver restores this ratio through hepatocyte renewal, resulting in the liver’s ability to maintain its many metabolic functions that are executed by hepatocytes. Organized into hexagonal lobular units, hepatocytes are stacked in between a central vein and a portal triad, which consists of a portal vein, hepatic artery, and bile duct. The directional flow of oxygenated blood from the portal to central axis creates a gradient of cytokines, nutrients, and growth factors throughout the liver lobule that influences hepatocyte transcriptome and function (<xref ref-type="bibr" rid="bib8">Halpern et al., 2017</xref>). Thus, pericentral hepatocytes, present near the central vein, receive different growth factor signals compared to the midlobular and periportal hepatocytes that occupy the rest of the liver lobule. Hepatocyte turnover along the liver lobule has been well characterized during ad libitum (AL) feeding (<xref ref-type="bibr" rid="bib4">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">He et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Lin et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Wei et al., 2021</xref>), when animals are given constant access to food. In these studies, hepatocytes have a detectable rate of turnover and division (<xref ref-type="bibr" rid="bib11">He et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Wei et al., 2021</xref>), but the proliferation rates compared to other tissues are low (<xref ref-type="bibr" rid="bib19">Michalopoulos, 2021</xref>). In contrast, no study so far has looked at hepatocyte turnover during periods of fasting and re-feeding, arguably a dietary state that more closely mimics nutrient availability and intake in natural populations, where periods of food availability fluctuate.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Rapid proliferation of pericentral hepatocytes occurs during intermittent fasting</title><p>To determine the impact of intermittent fasting (IF) on hepatocyte turnover, we compared the spatial expression of the proliferation marker Ki67, in 1- and 3-week IF-treated livers compared to AL-treated livers (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). We assessed the presence of Ki67+ hepatocytes throughout the liver lobule using a pericentral hepatocyte marker (glutamine synthetase) and a periportal hepatocyte marker (E-cadherin) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Total Ki67+ hepatocytes increased by 2-fold at 1 week of IF treatment compared to AL treatment (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). This increase was no longer observed at 3 weeks of IF treatment, suggesting that the increase in proliferation was short term (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The number of pericentral Ki67+ hepatocytes increased by approximately 120% after 1 week of IF treatment compared to AL treatment and 3 weeks of IF treatment (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). At 3 weeks of IF treatment, the number of Ki67+ hepatocytes returned to AL levels, and were predominately midlobular (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), as has been previously described (<xref ref-type="bibr" rid="bib11">He et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Wei et al., 2021</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Intermittent fasting (IF) induces rapid hepatocyte proliferation.</title><p>(<bold>A</bold>) Ki67 immunofluorescence for the detection of proliferating cells in ad libitum (AL), 1- and 3-week IF-treated livers. IF-treated livers were analyzed 30 min after re-feeding cycle. (<bold>B, C</bold>) Quantification of spatial distribution and percentage of Ki67+ hepatocytes in AL- and IF-treated livers. One-way analysis of variance (ANOVA), <italic>N</italic> = 4.(<bold>D</bold>) Dox inducible Axin2-rtTA; Teto-H2BGFP system to label Axin2+ pericentral hepatocytes and trace cell proliferation. Mice were pulsed with dox for 7 days, cleared of dox for 3 days and AL-fed or intermittently fasted for 6 days. (<bold>E</bold>) GFP immunofluorescent images showing increased hepatocyte expansion in AL and IF compared to T0. (<bold>F</bold>) Percentage of GFP+ hepatocyte nuclei in AL, IF livers from A. One-way ANOVA, <italic>N</italic> = 3 (T0), 5 (AL), 5 (IF). **p &lt; 0.01; *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm. wk, weeks.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Hepatocyte proliferation kinetics in ad libitum (AL) fed and intermittent fasted animals.</title><p>(<bold>A</bold>) Schematic of unbiased system to trace cell proliferation during AL feeding and intermittent fasting (IF). <italic>R26-CreER</italic> mice were crossed to <italic>R26-Confetti</italic> mice enabling permanent cell labeling and lineage tracing by four fluorescent reporters after tamoxifen administration. (<bold>B</bold>) At T0, mostly single, HNF4A+ hepatocytes were labeled throughout the lobule. At 1 and 3 weeks, multicellular hepatocytes clones (dotted circles) grew in AL and IF livers, with increased pericentral growth in IF. (<bold>C</bold>) The number of hepatocytes per 3D clone at each collection in A. One-way analysis of variance (ANOVA), 439–602 clones analyzed at T0, 430–1085 clones at 1 wk AL, 625–904 clones at 1 wk IF, 523–615 clones at 3 wk AL, and 442–615 at 3 wk IF. <italic>N</italic> = 3. (<bold>D</bold>) Percentage of 3D clones consisting of different cell sizes, from C, in different liver lobule locations. PC, pericentral; Mid, midlobular; PP, periportal. Differences between 1-, 2-, and &gt;3-cell clones in periportal and pericentral zones are indicated by p values above bars. Two-way ANOVA. <italic>N</italic> = 3. (<bold>E</bold>) Schematic of system to trace hepatocyte proliferation over 3 months of IF or AL treatment. Axin2-rtTA; Teto-Cre; <italic>Rosa26-mTmG</italic> mice were induced with tamoxifen enabling permanent cell labeling and lineage tracing by reporter GFP. (<bold>F</bold>) GFP immunofluorescent images highlighting Axin2+ hepatocyte tracing from T0, 1 week, 3 weeks, and 3 months after AL or IF treatment. ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Single-cell RNA-seq comparing hepatocytes in ad libitum (AL) fed and intermittent fasted livers.</title><p>(<bold>A</bold>) Violin plots, from scRNA-seq, demonstrating zonal marker gene expression used to classify single hepatocytes from AL and intermittent fasting (IF) livers as pericentral (PC), midlobular (Mid), and periportal (PP) hepatocytes. (<bold>B</bold>) Pie charts of hepatocyte zonal populations identified in scRNA-seq highlighting increase in PC hepatocytes in IF compared to AL livers. (<bold>C</bold>) Volcano plots highlighting differentially expressed transcripts in IF versus AL livers in PC, Mid, and PP hepatocytes. Red circles highlighting transcripts involved in de novo lipogenesis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig1-figsupp2-v1.tif"/></fig></fig-group><p>Next, we corroborated the rapid and positional shift in IF-induced hepatocyte proliferation by employing both random (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and pericentral-specific cell lineage tracing systems (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) to capture representative hepatocytes and trace their clonal expansion in the liver under an AL or IF feeding regimen. First, to study hepatocyte proliferation throughout the liver lobule, we employed an inducible, <italic>Rosa26-CreERT2</italic> (<xref ref-type="bibr" rid="bib37">Ventura et al., 2007</xref>) allele to permanently and randomly label cells with one of the four fluorophores in the <italic>Rosa26-Confetti</italic> allele (<xref ref-type="bibr" rid="bib31">Snippert et al., 2010</xref>). Following 2 weeks of tamoxifen clearance from the liver (time zero [T0], <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), greater than 95% of labeled cells coexpressed one of the fluorophores and the hepatocyte-specific transcription factor HNF4A (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), demonstrating labeling of mostly single hepatocyte clones distributed throughout the liver lobule (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Three weeks after IF feeding, a distinct increase in pericentral clone size was observed compared to AL-fed animals (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Second, to study pericentral hepatocyte proliferation kinetics during AL feeding and IF, we utilized an inducible system to mark and trace pericentral hepatocytes. In Axin2-rtTA; TetO-H2B-GFP transgenic mice (<xref ref-type="bibr" rid="bib35">Tumbar et al., 2004</xref>; <xref ref-type="bibr" rid="bib41">Yu et al., 2007</xref>), a modified promoter of the WNT transcriptional target gene, <italic>Axin2</italic>, is used to control expression of a stable histone 2B-GFP fusion protein with doxycycline (dox) administration, thus marking WNT-responsive, pericentral hepatocytes and their progeny (8). Importantly, in these mice the ectopic Axin2-rtTA expression cassette leaves the endogenous <italic>Axin2</italic> locus unchanged. Axin2rtTA; TetO-H2BGFP animals were given dox for 7 days, then cleared of dox for 3 days, and analyzed after dox clearance (T0) or after an additional 6 days of the AL or IF feeding regimen (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). We observed a 74% increase in GFP-labeled hepatocyte nuclei in IF-treated animals compared T0 animals, thus confirming expansion of pericentral hepatocytes (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>). No significant change was observed between AL and T0 animals. Additionally, we quantified pericentral hepatocyte proliferation kinetics between 1 week, 3 weeks, and 3 months of IF and AL treatment using Axin2-rtTA<italic>;</italic> Teto-Cre<italic>; Rosa26-mTmG</italic> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E, F</xref>). Notably, the majority of labeled hepatocyte expansion occurred within the first week of IF treatment. Together these data demonstrated the rapid and transient proliferation of pericentral hepatocytes during IF feeding.</p><p>As an independent means to characterize hepatocytes after IF treatment, we performed single-cell RNA sequencing on livers from 1-week IF- and AL-treated animals. Livers were collected during a matched, neutral feeding and circadian state. Sequenced hepatocytes were classified into pericentral, midlobular, and periportal hepatocytes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A, B</xref>), using well-characterized marker genes (<xref ref-type="bibr" rid="bib8">Halpern et al., 2017</xref>). The proportion of hepatocytes enriched for pericentral transcripts in IF-treated animals was 19.52 ± 4.9%, more than twice as much as the proportion observed in AL-treated animals, 8.97 ± 1.2%. The increased proportion of pericentral hepatocytes in IF-treated animals suggests that IF increases the number of pericentral hepatocytes rather than midlobular or periportal hepatocytes. Furthermore, within pericentral hepatocytes, gene expression analyses revealed a distinct increase in de novo lipogenesis genes (<italic>Fasn</italic>, <italic>Scd1</italic>, and <italic>Acyl</italic>) in IF compared to AL livers (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>), highlighting a cellular mechanism for the induction of de novo lipogenesis in the liver, a phenomenon previously observed during IF (<xref ref-type="bibr" rid="bib10">Hatchwell et al., 2020</xref>).</p></sec><sec id="s2-2"><title>Nutrient-responsive endocrine FGF15-β-KLOTHO signaling induces hepatocyte proliferation during IF</title><p>Endocrine fibroblast growth factor(FGF) signaling is critical in mediating an organism’s physiological response to fasting and re-feeding (<xref ref-type="bibr" rid="bib29">Potthoff et al., 2012</xref>). Upon re-feeding, FGF15, produced by intestinal enterocytes and perhaps other tissues too, travels through the bloodstream and binds to its co-receptor, β-KLOTHO (KLB), on hepatocytes (<xref ref-type="bibr" rid="bib12">Inagaki et al., 2005</xref>). Endocrine FGF signaling has also been shown to play important roles in regulating hepatocyte metabolism (<xref ref-type="bibr" rid="bib12">Inagaki et al., 2005</xref>; <xref ref-type="bibr" rid="bib28">Potthoff et al., 2011</xref>) and regeneration (<xref ref-type="bibr" rid="bib36">Uriarte et al., 2013</xref>). To investigate this further, we conducted a kinetic and a histology screen to identify when and where FGF15 acts on hepatocytes during IF. In IF-treated animals, Fgf15 expression was rapidly induced upon re-feeding, reaching maximal levels in the intestine within 30 min upon re-feeding (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), compared to AL animals which did not detectably express Fgf15 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Thirty minutes after re-feeding, downstream pathway components KLB, PHOSPHO-TYROSINE, and PHOSPHO-C-JUN were elevated in IF animals, and all of these three components were preferentially concentrated in the pericentral region (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Endocrine FGF15-β-KLOTHO (KLB) signaling is required for hepatocyte proliferation during intermittent fasting (IF).</title><p>(<bold>A</bold>) Quantitative real-time PCR analysis highlighting rapid increase in Fgf15 expression in ileum 30 min after re-feeding in 1-week IF-treated livers. One-way analysis of variance (ANOVA), comparison with time 0, <italic>N</italic> = 3. (<bold>B</bold>) Immunofluorescence for endocrine FGF pathway components highlighting pathway activation in 1-week IF-treated livers 30 min after re-feeding (ZT12). (<bold>C</bold>) Schematic of method to deplete hepatocytes of <italic>Klb</italic>. Axin2-rtTA; Teto-H2BGFP; <italic>Klb flox/flox</italic> mice were injected with AAV8-TTR-Cre (<italic>Klb</italic> KO). GFP and KLOTHO immunofluorescent images showing decrease in hepatocyte expansion and loss of KLOTHO in <italic>Klb</italic> KO compared to control livers. (<bold>D</bold>) Percentage of GFP+ hepatocyte nuclei in <italic>Klb</italic> KO and control livers. (<bold>E</bold>) Quantitative real-time PCR analysis confirming loss of <italic>Klb</italic> but not WNT target genes, <italic>Tbx3</italic> and <italic>Axin2</italic>, in <italic>Klb</italic> KO livers. Two-way ANOVA, <italic>N</italic> = 3. (<bold>F</bold>) Ploidy distribution of GFP+ hepatocyte nuclei incontrol IF and <italic>Klb</italic> KO IF livers. Unpaired <italic>t</italic>-test. <italic>N</italic> = 7 (control), 4 (<italic>Klb</italic> KO). **p &lt; 0.01, *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig2-v1.tif"/></fig><p>Given that endocrine FGF15 is an early regulator of the hepatocyte response to food intake, we asked whether loss of endocrine FGF signaling in hepatocytes would prevent IF-induced proliferation. To test this, we genetically depleted hepatocytes of the endocrine FGF receptor (<italic>Klb</italic>) and traced expansion of Axin2+ GFP-labeled cells during IF treatment (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Loss of <italic>Klb</italic> led to a 53% reduction in GFP-labeled pericentral hepatocyte nuclei compared to control animals after 1 week of an IF feeding regimen (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Importantly, loss of <italic>Klb</italic> did not impact WNT target gene expression (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), a critical regulator of hepatocyte zonation and function in the liver (<xref ref-type="bibr" rid="bib26">Perugorria et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Wang et al., 2015</xref>). Furthermore, loss of <italic>Klb</italic> did not significantly change GFP-labeled nuclei ploidy (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). In summary, these data emphasize the functional requirement for endocrine FGF15-β-KLOTHO signaling to promote IF-induced pericentral hepatocyte proliferation.</p></sec><sec id="s2-3"><title>WNT signaling and the WNT target gene <italic>Tbx3</italic> promote enhanced pericentral hepatocyte proliferation during IF</title><p>Next, we sought to understand why pericentral hepatocytes preferentially divided in response to IF, as FGF15 is a hormone and would be theoretically accessible to all hepatocytes. One hypothesis is that IF-induced hepatocyte proliferation additionally requires a second signal, which is concentrated near pericentral hepatocytes. Pericentral hepatocytes receive paracrine WNT signals from endothelial cells of the central vein, which is required to establish and maintain pericentral hepatocyte zonation and function in the liver (<xref ref-type="bibr" rid="bib26">Perugorria et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Wang et al., 2015</xref>). We tested whether ectopic and constitutive activation of the WNT pathway in midlobular and periportal hepatocytes, which typically do not receive WNT signaling, would promote hepatocyte proliferation under an IF feeding regimen. To ectopically activate WNT signaling, we genetically deleted the WNT repressor <italic>Apc</italic> by injecting mice ubiquitously expressing <italic>Cas9</italic> with an AAV8 carrying a guide RNA (sgRNA) directed against <italic>Apc</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Midlobular and periportal hepatocytes that had undergone CRISPR-Cas9 gene editing of <italic>Apc</italic> were identified by the expression of WNT target gene glutamine synthetase (GS). Remarkably, these WNT activated (GS+) cells remained mostly as single cells in AL treatment, however they clonally expanded under IF treatment (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Paracrine WNT and WNT target gene <italic>Tbx3</italic> promote hepatocyte proliferation during intermittent fasting (IF).</title><p>(<bold>A</bold>) Method to constitutively activate WNT signaling in midlobular, periportal cells. AAV8-U6-sgAPC was injected into the tail vein of <italic>Rosa26-Cas9</italic> mice. Animals were IF treated for 1 week before analysis. GS immunofluorescent images for detection of Apc mutant clones in ad libitum (AL) and IF livers. (<bold>B</bold>) The number of Apc mutant hepatocytes per 3D clone expand in IF compared to AL livers. Mann–Whitney test. 130 clones analyzed in AL. 74 clones analyzed in IF. <italic>N</italic> = 3. White dashed lines demarcate multicellular non-pericentral GS+ clones. (<bold>C</bold>) Schematic of method to deplete hepatocytes of the WNT target, <italic>Tbx3</italic>. Axin2-rtTA; Teto-H2BGFP; <italic>Tbx3flox/flox</italic> mice were intraperitoneally injected with AAV8-TTR-Cre (<italic>Tbx3</italic> KO). GFP and TBX3 immunofluorescent images to show IF-induced proliferation and <italic>Tbx3</italic> depletion, respectively, in control and <italic>Tbx3</italic> KO livers. (<bold>D</bold>) Percentage of GFP + hepatocyte nuclei decreased in Tbx3 KO IF compared to control IF livers. Unpaired <italic>t</italic>-test, (<italic>N</italic> = 7 control IF), <italic>N</italic> = 4 (<italic>Tbx3</italic> KO IF). (<bold>E, F</bold>) Nuclear ploidy distribution of GFP+ hepatocytes highlighting hyper-polyploidization in <italic>Tbx3</italic> KO IF compared to control IF livers. Two-way analysis of variance (ANOVA), <italic>N</italic> = 3. (<bold>G</bold>) Schematic for Fgf15 overexpression. Axin2-rtTA; Teto-H2BGFP; <italic>Tbx3 flox/flox</italic> mice were injected with AAV-TTR-FGF15 (Fgf15 OE) and AAV8-Null (control) or AAV-TTR-CRE (<italic>Tbx3</italic> KO). (<bold>H</bold>) GFP immunofluorescent images from c AL, Fgf15 OE AL, <italic>Tbx3</italic> KO AL, Fgf15 OE; <italic>Tbx3</italic> KO AL livers. (<bold>I</bold>) Percentage of GFP+ hepatocyte nuclei highlighting lack of hepatocyte proliferation in <italic>Tbx3</italic> KO livers. Unpaired <italic>t</italic>-test, <italic>N</italic> = 4. (<bold>J</bold>) Dot plot highlighting increase in nuclear area with Fgf15 overexpression both with and without <italic>Tbx3</italic>. Unpaired <italic>t</italic>-test. ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig3-v1.tif"/></fig><p>WNT signaling induces expression of the transcriptional repressor <italic>Tbx3</italic> in hepatocytes. Previous studies have demonstrated that <italic>Tbx3</italic> regulates division of hepatocytes during liver development by repressing cell cycle inhibitors (<xref ref-type="bibr" rid="bib13">Jin et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Suzuki et al., 2008</xref>). To determine if <italic>Tbx3</italic> plays a role in IF-induced hepatocyte proliferation, we genetically depleted <italic>Tbx3</italic> in hepatocytes and traced expansion of Axin2+ GFP-labeled cells after IF treatment (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Loss of <italic>Tbx3</italic> led to a 51% reduction in expansion of GFP-labeled cells after IF treatment (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Furthermore, loss of <italic>Tbx3</italic> increased nuclear ploidy in GFP-labeled cells, suggesting that pericentral hepatocytes underwent endoreplication rather than division (<xref ref-type="fig" rid="fig3">Figure 3E, F</xref>). These findings suggest that WNT and WNT-induced transcription factor TBX3 endow pericentral hepatocytes with capacity to divide during IF treatment.</p></sec><sec id="s2-4"><title>FGF15 signaling requires WNT/TBX3 to induce pericentral hepatocyte proliferation</title><p>Our results suggest that systemic FGF15 and paracrine WNT pathways may work together to push hepatocytes through the cell cycle. To directly test for an interdependent relationship between FGF and WNT signaling on hepatocyte division, we ectopically expressed <italic>Fgf15</italic> in the liver under AL feeding in the presence or absence of <italic>Tbx3</italic> (<xref ref-type="fig" rid="fig3">Figure 3G, H</xref>). Indeed, AAV-mediated Fgf15 overexpression, led to a 102% increase in Axin2+ GFP-labeled nuclei compared to control animals, (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). However, Fgf15 overexpression with <italic>Tbx3</italic> loss did not significantly increase hepatocyte division (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Interestingly, Fgf15 overexpression increased nuclear area both with and without loss of <italic>Tbx3</italic> (<xref ref-type="fig" rid="fig3">Figure 3J</xref>), suggesting that FGF signaling initiates S-phase, but requires WNT through TBX3 to complete mitosis. These results highlight the co-requirement of FGF15 and WNT signaling for pericentral hepatocyte proliferation.</p></sec><sec id="s2-5"><title>Hepatocyte proliferation or compensatory polyploidization maintains the hepatostat during IF</title><p>During partial hepatectomy where two thirds of the liver is removed or during liver transplantation from a smaller organism to a larger one, reduced liver cell mass relative to overall body size disrupts the hepatostat, the liver-to-body weight ratio required to maintain homeostasis (<xref ref-type="bibr" rid="bib20">Michalopoulos and Bhushan, 2021</xref>). Re-establishment of the hepatostat through hepatocyte regeneration is critical to prevent development of liver disease (<xref ref-type="bibr" rid="bib20">Michalopoulos and Bhushan, 2021</xref>). We asked whether the hepatostat was disrupted during IF. For early timeframes of IF (2–6 days), liver-to-body weight ratio significantly decreased during fasting and increased during re-feeding states compared to AL-treated livers (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). However, after 3 weeks of IF treatment, this ratio stabilized and was not significantly different between fasting, re-feeding or AL states.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Hepatocyte proliferation or compensatory polyploidization maintains the hepatostat during intermittent fasting (IF).</title><p>(<bold>A</bold>) Liver-to-body weight ratio in wild-type livers during 2 days, 1 week, and 3 weeks of IF and ad libitum (AL) feeding. (<bold>B–K</bold>) Liver analyses after 3 weeks of IF treatment in control, <italic>Klb</italic> KO, and <italic>Tbx3</italic> KO livers. (<bold>B</bold>) Liver-to-body weight ratio. (<bold>C</bold>) Hepatocyte nuclear area. (<bold>D</bold>) Nuclear ploidy distribution of pericentral hepatocytes with hyper-polyploidization in <italic>Tbx3</italic> KO IF livers. (<bold>E</bold>) Immunofluorescence images for β-CATENIN and HNF4A highlighting hepatocyte cell and nuclear area during IF. (<bold>F</bold>) AST and ALT liver injury marker presence in serum. (<bold>G</bold>) Quantification and representative images of senescence-associated β-galactosidase stains. (<bold>H</bold>) RNAscope images and quantification for pericentral marker Cyp2e1 and periportal marker Cyp2f2. (<bold>I</bold>) Metabolomics PCA plot comparing control IF, <italic>Klb</italic> KO IF, and <italic>Tbx3</italic> KO IF livers. (<bold>J</bold>) Volcano plots comparing metabolites between control AL and control IF livers and control AL and <italic>Klb</italic> KO IF livers. The top 3 most significantly changed bile metabolites are labeled in blue. (<bold>K</bold>) Expression of bile acid pathway enzymes genes in livers. Quantitative PCR for genes for critical enzymes in bile acid pathway. All statistics were performed on N=3-5 animals using one-way analysis of variance (ANOVA). ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Short-term loss of <italic>Tbx3</italic> or <italic>Klb</italic> does not disrupt the hepatostat during ad libitum (AL) feeding.</title><p>A-H AL <italic>Klb</italic> KO, AL <italic>Tbx3</italic> KO, and control AL livers were assessed at the same time point in <xref ref-type="fig" rid="fig4">Figure 4</xref> (3 weeks after AL feeding). (<bold>A</bold>) Liver-to-body weight ratio. (<bold>B, C</bold>) Hepatocyte cell and nuclear area. (<bold>D</bold>) Immunofluorescence images forβ-CATENIN and HNF4A highlighting hepatocyte cell and nuclear area during AL livers. (<bold>E</bold>) AST and ALT liver injury marker presence in serum. (<bold>F</bold>) Quantification and representative images of senescence-associated β-galactosidase stains. (<bold>G</bold>) RNAscope for pericentral marker <italic>Cyp2e1</italic> and periportal marker <italic>Cyp2f2</italic>. All statistics were performed on N=3-5 animals using one-way analysis of variance (ANOVA). ****p &lt; 0.0001, *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Fibrosis and cell death assessment of Control, <italic>Klb</italic> KO, and <italic>Tbx3</italic> KO IF- and ad libitum (AL)-treated livers.</title><p>(<bold>A, B</bold>) Sirius red staining and quantification to assess for liver fibrosis. (<bold>C</bold>) TUNEL stains on livers. All statistics were performed on N=3-5 animals using one-way analysis of variance (ANOVA). *p &lt; 0.05. Error bars indicate standard deviation. Scale bar, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Given the re-establishment of the hepatostat after 3 weeks of IF, we then asked if the transient hepatocyte proliferation observed during early timeframes of IF was required to reach homeostasis after 3 weeks of IF. To test this, we compared the liver-to-body weight ratios, hepatocyte cell and nuclear areas between livers depleted of <italic>Klb</italic> or <italic>Tbx3</italic> and AL-fed or intermittently fasted for 3 weeks. In AL-treated animals, loss of <italic>Klb</italic> did not significantly alter the liver-to-body weight ratio, nor hepatocyte cell and nuclear area compared to control livers (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). In contrast, in IF-treated animals, loss of <italic>Klb</italic> led to a significant decrease compared to control livers (<xref ref-type="fig" rid="fig4">Figure 4B–E</xref>). Livers depleted of <italic>Tbx3</italic> were able to maintain liver-to-body weight ratios, hepatocyte cell and nuclear area similar to control livers during AL and IF treatment (<xref ref-type="fig" rid="fig4">Figure 4B–E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). Importantly, IF-treated livers depleted of <italic>Tbx3</italic> exhibited hyper polyploidization of pericentral hepatocytes (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These findings highlight the importance of hepatocyte proliferation during IF to maintain the hepatostat. Moreover, they demonstrate the ability of hepatocytes to undergo endoreplication and polyploidization, in the absence of division, as a compensatory mechanism to maintain liver size.</p><p>To determine the functional consequence of loss of hepatocyte proliferation during IF, we analyzed fibrosis and cell death in control, <italic>Klb</italic> KO, or <italic>Tbx3</italic> KO livers under IF or AL feeding regimens (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–C</xref>). Despite the significant reduction in liver-to-body weight ratio with loss of <italic>Klb</italic> during IF, we did not observe an increase in fibrosis or dying (TUNEL+) hepatocytes with loss of <italic>Klb</italic> or loss of <italic>Tbx3</italic> during IF treatment. However, we did observe a greater than three-fold increase in transaminase AST and ALT—widely used markers of liver injury—in serum from <italic>Klb</italic> KO IF-treated livers compared to control IF and <italic>Tbx3</italic> KO IF-treated livers (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). We also observed a striking increase in pericentral-localized hepatocyte senescence in <italic>Klb</italic> KO IF-treated livers compared to control IF and <italic>Tbx3</italic> KO IF-treated livers (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Furthermore, hepatocyte senescence and serum transaminase levels were elevated by two-fold in <italic>Klb</italic> KO IF-treated livers compared to <italic>Klb</italic> KO AL-treated livers (<xref ref-type="fig" rid="fig4">Figure 4F, G</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E, F</xref>). These two findings demonstrate that when compensatory hepatocyte proliferation is blocked during IF, liver pathology ensues.</p><p>To further support these findings, we performed zonation studies and metabolomics to identify additional functional consequences of compromised hepatocyte proliferation during IF. These analyses highlighted marked changes in zonation (<xref ref-type="fig" rid="fig4">Figure 4H</xref>) as well as liver metabolites (<xref ref-type="fig" rid="fig4">Figure 4I</xref>) between control IF and <italic>Klb</italic> KO IF-treated livers. Curiously, differences in metabolites between IF and AL samples were lost when <italic>Klb</italic> was lost during IF treatment (<xref ref-type="fig" rid="fig4">Figure 4J</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) indicating that the hepatocyte metabolism required to maintain the hepatostat during IF was impaired when hepatocyte proliferation and polyploidization was lost. To further test this, we examined the zonation and expression of genes important in production of bile acids, the most strongly changed metabolites between IF and AL. Importantly, <italic>Cyp7a1</italic>, a gene that is pericentrally expressed in the normal liver (<xref ref-type="bibr" rid="bib8">Halpern et al., 2017</xref>), is dysregulated by threefold with loss of <italic>Klb</italic> during IF treatment (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). These data combined demonstrate that loss of division of pericentral cells during IF has important functional consequences for the liver including a decrease in the liver-to-body weight ratio, increased pericentral hepatocyte senescence, and irregular liver zonation and metabolism.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The liver is thought to be mostly quiescent except in the presence of injury. Our data overturn this view by demonstrating that the liver is exquisitely tuned to changes in nutrient status and deploys robust homeostatic mechanisms to ensure a constant liver-to-body weight ratio during fasting and re-feeding. In order to proliferate in response to IF, hepatocytes integrate nutrient sensing responses, mediated via FGF15, with knowledge of cellular position, mediated by local, pericentral WNT signals. Pericentral hepatocyte proliferation ensures replacement of lost cellular mass through increases in overall cell numbers. We propose a working model in which paracrine WNT and endocrine FGF pathways work together to push hepatocytes through different phases of the cell cycle. The role of FGF15 in pericentral hepatocyte proliferation observed in our studies suggests that this signal initiates S-phase, whereas WNT through TBX3 permits progression through M-phase. It has been demonstrated in other contexts as well that both FGF and WNT signaling are conjointly required for tissue growth (<xref ref-type="bibr" rid="bib18">McGrew et al., 1997</xref>; <xref ref-type="bibr" rid="bib33">ten Berge et al., 2008</xref>). Whether or not timing of re-feeding and dosage of FGF15, WNT, and TBX3 impact location and degree of hepatocyte proliferation remain important questions for future studies.</p><p>It will be of interest to know how the hepatostat is maintained during other nutrient conditions such as ketogenic, calorie restricted, or high-fat diets. Many tissues in the body are known to be slowly proliferating, but this conclusion has mainly stemmed from AL-fed mouse studies, which may not mimic the IF that wild animals are exposed to during times of fluctuating food abundance. These studies demonstrate that there is perhaps more proliferative capacity than previously appreciated in tissues that are currently thought to exhibit a slow turnover rate. This would have implications for how we understand regulation of both stem and non-stem cell populations in many other tissues and organs.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mouse strains, husbandry, and experimental methods</title><p>All experiments were done on adult, 8- to 12-week-old, male mice, unless otherwise noted. Wild type <italic>C57BL/6</italic> J mice, <italic>Rosa26-CreERT2</italic> (<xref ref-type="bibr" rid="bib37">Ventura et al., 2007</xref>), <italic>Rosa26-Confetti</italic> (<xref ref-type="bibr" rid="bib31">Snippert et al., 2010</xref>), <italic>Axin2-rtTA</italic> (<xref ref-type="bibr" rid="bib41">Yu et al., 2007</xref>), <italic>TetO-H2B-GFP</italic> (<xref ref-type="bibr" rid="bib35">Tumbar et al., 2004</xref>); <italic>Rosa 26-mTmG</italic> (<xref ref-type="bibr" rid="bib22">Muzumdar et al., 2007</xref><xref ref-type="bibr" rid="bib22">Muzumdar et al., 2007</xref>) and <italic>Rosa26-Cas9</italic> (<xref ref-type="bibr" rid="bib27">Platt et al., 2014</xref>) strains were obtained from The Jackson Laboratory (JAX, Bar Harbor, ME, see Key Resources Table). <italic>Tbx3 flox</italic> mice were a gift from Dr. Anne Moon (<xref ref-type="bibr" rid="bib7">Frank et al., 2012</xref>). <italic>Klb</italic> flox mice were a gift from Dr. David Mangelsdorf (<xref ref-type="bibr" rid="bib5">Ding et al., 2012</xref>). All mice were housed in the animal facility of Stanford University on a 12 hr light/dark cycle (0700/1900 hr) AL access to water and food (standard chow diet with 18% calories derived from fat, 24% calories from protein, and 58% calories from carbohydrates, Tekland 2918).</p><p>For all IF, mice were randomly assigned into AL or IF groups. IF was performed with total food deprivation and AL access to water from approximately 1900 to 1900 hr the following day to implement alternate periods of 24 hr fasting and feeding. Unless specified otherwise in text and figures, all samples were collected for both AL and IF groups at 1200 hr to access samples during a neutral metabolic and circadian rhythm time point.</p><p>For random cell lineage tracing studies, <italic>Rosa26-CreERT2</italic>/<italic>Rosa26-Conf</italic>etti mice received intraperitoneal injections of tamoxifen (TAM; 4 mg/25 g mouse weight, Sigma, St. Louis, MO) dissolved in 10% ethanol/corn oil (Sigma, St. Louis, MO) twice with 48 hr between injections. Two weeks after the last tamoxifen injection, livers where immediately analyzed (T0) or analyzed after an additional 1–3 weeks of AL feeding or IF.</p><p>For Axin2+ cell lineage tracing studies, mice received doxycycline hycalate (Dox; 1 mg/ml; Sigma, St. Louis, MO) in drinking water for 5 days. Dox water was then replaced with normal drinking water for 3 days before livers were immediately analyzed (T0) or analyzed after an additional 1 week, 3 weeks, and 3 months of AL feeding or IF.</p><p>For all AAV studies, mice were intraperitoneally injected with 1 × 10<sup>11</sup> genome copies per mouse at 6–8 weeks of age to induce liver-specific depletion of <italic>Klb</italic> or <italic>Tbx3</italic> (AAV8-TTR-Cre, Vector Bio Labs, Malvern, PA), Fgf15 overexpression (AAV8-TTR-FGF15; Addgene deposit 81516), or <italic>Apc</italic> gene editing (AAV8-U6-sgAPC; derived from Clontech 632609). For AAV control studies, an AAV8-Null vector containing no transgene (Vector Bio Labs, Malvern, PA) was used on a combined cohort of <italic>Tbx3 flox</italic>/<italic>flox</italic> and <italic>Klb flox</italic>/<italic>flox</italic> mice. For studies that combined AAV injection and Axin2+ cell lineage tracing, mice were first injected with AAV, allowed 3 days to recover and subsequently treated with dox water to induce tracing.</p><p>All animal experiments and methods were approved by the Institutional Animal Care and Use Committee at Stanford University. In conducting research using animals, the investigators adhered to the laws of the United States and regulations of the Department of Agriculture.</p></sec><sec id="s4-2"><title>Tissue collection, processing, staining, and imaging</title><p>For clonal analysis and KLOTHO immunofluorescence, mice were perfused with 4% paraformaldehyde (PFA), livers were isolated and further fixed in 4% PFA for 2 hr at 4°C. PFA-fixed tissues were washed in phosphate-buffered saline (PBS) and sectioned into 50–200 µm sections using a Compresstome vibrating microtome tissue slicer (VF-310-0Z, Precisionary). Vibratome sections from the median lobe were then permeabilized, stained and cleared using a method developed by the Zerial lab (<ext-link ext-link-type="uri" xlink:href="https://www.zeriallab.org/">https://www.zeriallab.org/</ext-link>). Antibodies and dilutions described in Key Resources Table. Vibratome sections were imaged using an SP8 White Light Laser Confocal microscope (Lecia, Weltzar, Germany) and a BZ-X800 microscope (Keyence, Osaka, Japan). Confocal image stacks were acquired at ×20 magnification and up to 100 μm with a step size of 1 μm along the <italic>Z</italic>-axis and processed and analyzed with Imaris software.</p><p>For endocrine FGF signaling pathway analyses (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), livers were flash frozen in OCT, cryo-sectioned at 10 µm, fixed for 15 min in 4% PFA at room temperature and then stained. Antibodies and dilutions described in Key Resources Table.</p><p>For histology and immunohistochemistry, liver was fixed overnight in 10% formalin at room temperature, dehydrated, cleared in HistoClear (Natural Diagnostics), and embedded in paraffin. Sections were cut at 5 μm thickness, de-paraffinized, re-hydrated, and processed for further staining via immunofluorescence or in situ hybridization assays as described below.</p><p>For histology, formalin-fixed paraffin-embedded liver sections were sent to the Department of Comparative Medicine’s Animal Histology Services for Sirius Red staining.</p><p>For immunofluorescence, sections of formalin-fixed paraffin-embedded livers were subjected to antigen retrieval with Tris buffer pH = 8.0 (Vector Labs H-3301, Newark, CA) in a pressure cooker. They were then blocked in 5% normal donkey serum in PBS containing 0.1% Triton X, in combination with the Avidin/Biotin Blocking reagent (Vector Labs SP-2001, Newark, CA). Sections were incubated with primary and secondary antibodies and mounted in Prolong Gold with DAPI medium (Invitrogen, Waltham, MA). Biotinylated goat antibody was applied to section stained with TBX3, before detection with Streptavidin-647. Antibodies and dilutions described in Key Resources Table. Samples were imaged at ×20 magnification using an Sp8 Confocal or a Zeiss Imager Z.2 and processed and analyzed with ImageJ software.</p></sec><sec id="s4-3"><title>Senescence-associated β-galactosidase staining and TUNEL assay</title><p>For senescence-associated β-galactosidase staining, flash frozen livers were cryo-sectioned at 10 μm and fixed with 0.5% glutaraldehyde in PBS for 15 min, washed with PBS supplemented with 1 mM MgCl<sub>2</sub> and stained for 14 hr in PBS containing (1 mM MgCl<sub>2</sub>; 1 mg/ml X-Gal and 5 mM of each of potassium ferricyanide and potassium ferrocyanide). Assay was performed at pH = 5.5 as previously described (<xref ref-type="bibr" rid="bib15">Krizhanovsky et al., 2008</xref>). Hematoxylin was used as a counterstain.</p><p>To detect apoptosis in livers, formaldehyde-fixed paraffin-embedded sections were detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay (Thermo Fisher Scientific, C10619, Waltham, MA) according to the manufacturer’s instructions.</p></sec><sec id="s4-4"><title>RNAscope in situ hybridization</title><p>In situs were performed using the RNAscope 2.5 HD Duplex Reagent Kit (Advanced Cell Diagnostics, Newark, CA) according to the manufacturer’s instructions. Images were taken at ×20 magnification on a Zeiss Imager Z.2 and processed using ImageJ software. Probes used in this study were <italic>Cyp2f2</italic> (target region: 555–1693) and <italic>Cyp2e1</italic> (target region: 458–1530).</p></sec><sec id="s4-5"><title>Fibrosis assay</title><p>Bright-field images were collected on a Zeiss Imager Z.2. Red stained collagen levels were quantified using ImageJ (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imagej.nih.gov</ext-link>).</p></sec><sec id="s4-6"><title>Clone size, number, and location</title><p>To quantify clone size, threshold of fluorescent channels was lowered so that clear cell and nuclear boundaries could be distinguished. One large-stitched image with an area of 1.8 × 1.8 × 0.1 mm<sup>3</sup> mouse was taken from two representative vibratome sections from each mouse at each time point. Only clones completely within the tissue sample were analyzed. We counted the total number of clones from the six representative images. Because images were of equal area, clone numbers can be compared to each other between time points. Clones containing a cell located within three cell distances from the portal vein or bile duct were classified as periportal; clones containing a cell within three cell distances from the central vein were classified as pericentral; clones not meeting either criterion were classified as midlobular. For clone size quantification in the AAV8-U6-sgAPC model, only GS+ clones that had discrete boundaries, one or more GS-negative hepatocytes from surrounding GS+ pericentral cells, were quantified .</p></sec><sec id="s4-7"><title>Hepatocyte nuclei isolation and analysis</title><p>For hepatocyte nuclei isolation, liver lobes from mice were homogenized in cold 1% formaldehyde in PBS with a loose pestle and Dounce homogenizer. Samples were then fixed for 10 min at room temperature followed by incubation for 5 min with glycine at a final concentration of 0.125 M. Samples were centrifuged at 300 × <italic>g</italic> for 10 min, at 4°C. Pellets were washed in PBS and re-suspended with 10 ml cell lysis buffer (10 mM Tris–HCl, 10 mM NaCl, 0.5% IGEPAL) and filtered through 100 μm cell strainers. A second round of homogenization was performed by 15–20 strokes with a tight pestle. Nuclei were pelleted at 2000 × <italic>g</italic> for 10 min at 4°C and re-suspended in 0.5 ml PBS and 4.5 ml of pre-chilled 70% ethanol and stored at −20°C before downstream GFP content and ploidy analysis by flow cytometry.</p><p>Right before flow cytometry, 1 million nuclei were re-suspended in PBS and stained with FxCycle PI/RNase (Thermo Fisher, F10797, Waltham, MA) staining solution for 15–30 min at room temperature. Cells were analyzed on an FACS ARIA II (BD). Data were processed with FACS Diva 8.0 software (BD) and FlowJo v10 (FlowJo). Doublets were excluded by FSC-W × FSC-H and SSC-W × SSC-H analysis. Single-stained channels were used for compensation and fluorophore minus one control was used for gating.</p></sec><sec id="s4-8"><title>Real-time PCR measurement</title><p>Liver samples were homogenized in TRIzol (Invitrogen, Waltham, MA) with a bead homogenizer (Sigma, St. Louis, MO). Total RNA was purified using the RNeasy Mini Isolation Kit (Qiagen, Hilden, Germany) and reverse transcribed (High Capacity cDNA Reverse Transcription Kit; Life Technologies, Carlsbad, CA) according to the manufacturer’s protocol. Quantitative RT-PCR was performed with TaqMan Gene Expression Assays (Applied Biosystem, Waltham, MA) on an StepOnePlus Real-Time PCR System (Applied Biosystems, Waltham, MA). Relative target gene expression levels were calculated using the delta-delta CT method (<xref ref-type="bibr" rid="bib17">Livak and Schmittgen, 2001</xref>). Gene Expression Assays used were <italic>Gapdh</italic> (Mm99999915_g1) as control, <italic>Klb</italic> (Mm00473122_m1), <italic>Axin2</italic> (Mm00443610_m1), <italic>Fgf15</italic>(Mm00433278_m1), and <italic>Tbx3</italic> (Mm01195719_m1) all from Thermo Fisher Scientific (Waltham, MA).</p></sec><sec id="s4-9"><title>Single-cell RNA sequencing</title><p>Hepatocytes were isolated from livers of 8-week-old C57BL/6J mice that had been intermittent fasted for 1 week or AL-fed using a two-step collagenase perfusion technique as previously described (<xref ref-type="bibr" rid="bib25">Peng et al., 2018</xref>).</p><p>Collections were performed at 1000 hr and during the feeding cycle of IF. For each feeding regimen, three livers were collected and processed as three individual samples. For each sample, 2000 hepatocytes were loaded to target ~1000 cells after recovery according to the manufacturer’s protocol. Single cell libraries were prepared using the 10× Genomics Chromium Single Cell 3″ Reagents Kit V3. Single-cell libraries were loaded on an Illumina NovaSeq 6000 instrument with NovaSeq S2 v.1.5 Reagent Kits with the following reads: 28 bases Read 1 (cell barcode and unique molecular identifier [UMI]), 8 bases i7 Index 1 (sample index), and 91 bases Read 2 (transcript).</p><p>Sample demultiplexing, barcode processing, single-cell counting, and reference genome mapping were performed using the Cell Ranger Software (v3.1.0, mm10 ref genome) according to the manual. All samples were normalized to present the same effective sequencing depth by using Cell Ranger aggr function. The dimensionality reduction by principal components analysis (PCA), the graph-based clustering and UMAP visualization were performed using Seurat (v3.0, R package). Genes that were detected in less than three cells were filtered out, and cells were filtered out with greater than 10% of mitochondrial genes and with fewer than 200 or greater than 50,000 detected genes.</p><p>For cell clustering, R software was used to sort cells into either pericentral (PC), midlobular (Mid), and periportal (PP) classes based on the greatest expression of biomarkers <italic>Cyp2e1</italic>, <italic>Cyp1a2</italic>, <italic>Glul</italic> (for PC), <italic>Hamp</italic> and <italic>Igfbp2</italic> (for Mid), and <italic>Cyp2f2</italic> and <italic>Cps1</italic> (for PP).</p></sec><sec id="s4-10"><title>Generation of AAV expression vectors</title><p>The AAV-TTR-FGF15 virus was produced from the complementary stand AAVS construct, csAAV-TTR-CRE plasmid (kind gift of Holger Willenbring). The <italic>CRE</italic> gene was excised by digestion with SalI (NEB). The <italic>Fgf15</italic> gene (GenBank: BC021328 cloneID 5066286) was amplified for assembly into the SalI cut AAV-TTR backbone with NEB HiFi Builder using the primers: (FWD) 5′ <named-content content-type="sequence">ggagaagcccagctgGTCGACGCCACCATGGCGAGAAAGTGGAACGG </named-content>3′ and (REV) 5′ <named-content content-type="sequence">atcagcgagctctaGTCGACTCATTTCTGGAAGCTGGGACTCTTCAC </named-content>3′. The two fragments were assembled with NEB HiFi builder and cloned in NEB Stable <italic>E. coli</italic>.</p><p>The AAV-sgApc virus was produced from the pAAV-Guide-it-Down construct (Clontech Laboratories Inc, 041315) using assembly primers:</p><list list-type="simple"><list-item><p>(FWD) 5′<named-content content-type="sequence">CCGGAGGCTGCATGAGAGCACTTG3′</named-content> and</p></list-item><list-item><p>(Rev) 5′<named-content content-type="sequence">AAACCAAGTGCTCTCATGCAGCCT3′</named-content>.</p><p>AAV-sgApc contains a U6 promoter and an sgRNA targeting the sequence 5′<named-content content-type="sequence">AGGCTGCATGAGAGCACTTG3′</named-content> in exon 13 of <italic>Apc</italic>.</p></list-item></list></sec><sec id="s4-11"><title>Metabolite extraction</title><p>Livers were harvested and immediately flash frozen in LN2 then stored at −80°C. While kept on dry ice a 20-mg sample was removed from each liver specimen, massed using an analytical balance, and placed in a 2-ml round bottom polypropylene tube containing 4–6, 2.3-mm stainless steel beads. 500 µl of −20°C extraction solution (methanol:acetonitrile:water, 2:2:1) containing stable isotope-labeled metabolite standards was added to each sample tube. Ratio of 20 mg to 500 µl was retained when masses were not exactly 20 mg. All samples were homogenized at an amplitude of 20 Hz for 15 min and stored at −20°C for 1 hr to maximize protein precipitation. Samples were then vortexed for 20 s and centrifuged at 4°C for 5 min, speed 14,000 rcf. 120 µl of supernatant was removed from each tube and filtered using 0.2-µm polyvinylidene fluoride filter (Agilent Technologies P/N: 203980-100) and collected via 6000 rcf centrifuge for 4 min. An additional 50 µl was removed from each sample and combined into five pooled samples analyzed at equal intervals throughout the analysis to ensure stable signal. Extracts, pools, and procedural blanks were sealed and stored at 4°C until prompt analysis.</p></sec><sec id="s4-12"><title>HILIC–MS/MS metabolite data collection and processing</title><p>Untargeted metabolomics analysis was conducted as described previously (<xref ref-type="bibr" rid="bib9">Han et al., 2021</xref>) with some modification. Liver extracts were analyzed via hydrophilic interaction liquid chromatography (HILIC) coupled to a Thermo Q-Exactive HF high resolution mass spectrometer. Each sample was analyzed in both positive and negative ionization modes (ESI+, ESI−) via subsequent injections. Full MS-ddMS2 data were collected, an inclusion list was used to prioritize MS2 selection of metabolites from our in-house ‘local’ library, when additional scan bandwidth was available MS2 was collected in a data-dependent manner. Mass range was 60–900 <italic>m</italic>/<italic>z</italic>, resolution was 60 k (MS1) and 15 k (MS2), centroid data were collected, loop count was 4, isolation window was 1.5 Da. Metabolomics data were processed using MS-DIAL v4.60 (<xref ref-type="bibr" rid="bib34">Tsugawa et al., 2020</xref>) and queried against a combination of our in-house MS2 library (<xref ref-type="bibr" rid="bib9">Han et al., 2021</xref>) and MassBank of North America, the largest freely available spectral repository (<xref ref-type="bibr" rid="bib14">Kind et al., 2018</xref>). Annotations were scored using guidelines from the metabolomics standards initiative (<xref ref-type="bibr" rid="bib30">Sansone et al., 2007</xref>). Features were excluded from analysis if peak height was not at least fivefold greater in one or more samples compared to the procedural blank average. Statistical analysis of annotated features was implemented using MetaboAnalyst 5.0 (<xref ref-type="bibr" rid="bib24">Pang et al., 2021</xref>). Data visualization including principal component analysis and volcano plots were generated using log10 transformed peak heights.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con12"><p>Resources, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con14"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments and methods were approved by the Institutional Animal Care and Use Committee at Stanford University.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Metabolomics intermittent fasting (IF) versus ad libitum (AL significantly changed metabolites between IF and AL samples from metabolomic studies).</title></caption><media xlink:href="elife-82311-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-82311-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Single-cell RNA sequencing has been deposited in GEO under accession number GSE211693. Metabolomics has been deposited in Metabolomics Workbench by NIH Common Fund's National Metabolomics Data Repository (NMDR); Project DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21228/M8Z119">https://doi.org/10.21228/M8Z119</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>DeFelice</surname><given-names>BC</given-names></name><name><surname>Logan</surname><given-names>CY</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Anbarchian</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Morri</surname><given-names>M</given-names></name><name><surname>Neff</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Rulifson</surname><given-names>E</given-names></name><name><surname>Fish</surname><given-names>M</given-names></name><name><surname>Kaye</surname><given-names>AG</given-names></name><name><surname>Martínez Jaimes</surname><given-names>AM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Intermittent fasting induces rapid hepatocyte proliferation to restore the hepatostat in the mouse liver</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE211693">GSE211693</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>DeFelice</surname><given-names>BC</given-names></name><name><surname>Logan</surname><given-names>CY</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Anbarchian</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Morri</surname><given-names>M</given-names></name><name><surname>Neff</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Rulifson</surname><given-names>E</given-names></name><name><surname>Fish</surname><given-names>M</given-names></name><name><surname>Kaye</surname><given-names>AG</given-names></name><name><surname>Martínez Jaimes</surname><given-names>AM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Intermittent fasting induces rapid hepatocyte proliferation to restore the hepatostat in the mouse liver</data-title><source>Metabolomics Workbench</source><pub-id pub-id-type="accession" xlink:href="https://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Project&amp;ProjectID=PR001445">PR001445</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank KM Loh and N Torok for constructive feedback on the manuscript; the Chan Zuckerberg Biohub Community Access Program for use of 10× Genomics equipment and sequencing; Stanford Neuroscience Gene and Vector Virus Core for virus production; and H Willenbring for sharing the csAAV-TTR-CRE plasmid. This study was supported by the Howard Hughes Medical Institute (HHMI) and the Stinehart Reed Foundation. AS was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Cancer Research Program, under Award No. W81XWH-17-1-0245. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. PW was supported by the Damon Runyon Cancer Research Foundation (DRSG-28P-19). The Genetics Bioinformatics Service Center of Stanford Cancer Institute’s Share Resource Facility was supported by NIH grant P30 CA124435.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandhorst</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>IY</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>CW</given-names></name><name><surname>Sedrakyan</surname><given-names>S</given-names></name><name><surname>Navarrete</surname><given-names>G</given-names></name><name><surname>Dubeau</surname><given-names>L</given-names></name><name><surname>Yap</surname><given-names>LP</given-names></name><name><surname>Park</surname><given-names>R</given-names></name><name><surname>Vinciguerra</surname><given-names>M</given-names></name><name><surname>Di Biase</surname><given-names>S</given-names></name><name><surname>Mirzaei</surname><given-names>H</given-names></name><name><surname>Mirisola</surname><given-names>MG</given-names></name><name><surname>Childress</surname><given-names>P</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Groshen</surname><given-names>S</given-names></name><name><surname>Penna</surname><given-names>F</given-names></name><name><surname>Odetti</surname><given-names>P</given-names></name><name><surname>Perin</surname><given-names>L</given-names></name><name><surname>Conti</surname><given-names>PS</given-names></name><name><surname>Ikeno</surname><given-names>Y</given-names></name><name><surname>Kennedy</surname><given-names>BK</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Morgan</surname><given-names>TE</given-names></name><name><surname>Dorff</surname><given-names>TB</given-names></name><name><surname>Longo</surname><given-names>VD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>86</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.012</pub-id><pub-id pub-id-type="pmid">26094889</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerletti</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>YC</given-names></name><name><surname>Finley</surname><given-names>LWS</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Short-term calorie restriction enhances skeletal muscle stem cell function</article-title><source>Stem Cell</source><volume>10</volume><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.04.002</pub-id><pub-id pub-id-type="pmid">22560075</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Astle</surname><given-names>CM</given-names></name><name><surname>Harrison</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hematopoietic senescence is postponed and hematopoietic stem cell function is enhanced by dietary restriction</article-title><source>Experimental Hematology</source><volume>31</volume><fpage>1097</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1016/s0301-472x(03)00238-8</pub-id><pub-id pub-id-type="pmid">14585375</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Jimenez</surname><given-names>RJ</given-names></name><name><surname>Sharma</surname><given-names>K</given-names></name><name><surname>Luu</surname><given-names>HY</given-names></name><name><surname>Hsu</surname><given-names>BY</given-names></name><name><surname>Ravindranathan</surname><given-names>A</given-names></name><name><surname>Stohr</surname><given-names>BA</given-names></name><name><surname>Willenbring</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Broad distribution of hepatocyte proliferation in liver homeostasis and regeneration</article-title><source>Stem Cell</source><volume>26</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.11.001</pub-id><pub-id pub-id-type="pmid">31866223</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Boney-Montoya</surname><given-names>J</given-names></name><name><surname>Owen</surname><given-names>BM</given-names></name><name><surname>Bookout</surname><given-names>AL</given-names></name><name><surname>Coate</surname><given-names>KC</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ΒKlotho is required for fibroblast growth factor 21 effects on growth and metabolism</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>387</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.08.002</pub-id><pub-id pub-id-type="pmid">22958921</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ertl</surname><given-names>RP</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Astle</surname><given-names>CM</given-names></name><name><surname>Duffy</surname><given-names>TM</given-names></name><name><surname>Harrison</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated</article-title><source>Blood</source><volume>111</volume><fpage>1709</fpage><lpage>1716</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-01-069807</pub-id><pub-id pub-id-type="pmid">17947508</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DU</given-names></name><name><surname>Carter</surname><given-names>KL</given-names></name><name><surname>Thomas</surname><given-names>KR</given-names></name><name><surname>Burr</surname><given-names>RM</given-names></name><name><surname>Bakker</surname><given-names>ML</given-names></name><name><surname>Coetzee</surname><given-names>WA</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><name><surname>Bamshad</surname><given-names>MJ</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>Moon</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lethal arrhythmias in tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasis</article-title><source>PNAS</source><volume>109</volume><fpage>E154</fpage><lpage>E163</lpage><pub-id pub-id-type="doi">10.1073/pnas.1115165109</pub-id><pub-id pub-id-type="pmid">22203979</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname><given-names>KB</given-names></name><name><surname>Shenhav</surname><given-names>R</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Toth</surname><given-names>B</given-names></name><name><surname>Lemze</surname><given-names>D</given-names></name><name><surname>Golan</surname><given-names>M</given-names></name><name><surname>Massasa</surname><given-names>EE</given-names></name><name><surname>Baydatch</surname><given-names>S</given-names></name><name><surname>Landen</surname><given-names>S</given-names></name><name><surname>Moor</surname><given-names>AE</given-names></name><name><surname>Brandis</surname><given-names>A</given-names></name><name><surname>Giladi</surname><given-names>A</given-names></name><name><surname>Avihail</surname><given-names>AS</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Cell spatial reconstruction reveals global division of labour in the mammalian liver</article-title><source>Nature</source><volume>542</volume><fpage>352</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1038/nature21065</pub-id><pub-id pub-id-type="pmid">28166538</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Van Treuren</surname><given-names>W</given-names></name><name><surname>Fischer</surname><given-names>CR</given-names></name><name><surname>Merrill</surname><given-names>BD</given-names></name><name><surname>DeFelice</surname><given-names>BC</given-names></name><name><surname>Sanchez</surname><given-names>JM</given-names></name><name><surname>Higginbottom</surname><given-names>SK</given-names></name><name><surname>Guthrie</surname><given-names>L</given-names></name><name><surname>Fall</surname><given-names>LA</given-names></name><name><surname>Dodd</surname><given-names>D</given-names></name><name><surname>Fischbach</surname><given-names>MA</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A metabolomics pipeline for the mechanistic interrogation of the gut microbiome</article-title><source>Nature</source><volume>595</volume><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03707-9</pub-id><pub-id pub-id-type="pmid">34262212</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatchwell</surname><given-names>L</given-names></name><name><surname>Harney</surname><given-names>DJ</given-names></name><name><surname>Cielesh</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>K</given-names></name><name><surname>Koay</surname><given-names>YC</given-names></name><name><surname>O’Sullivan</surname><given-names>JF</given-names></name><name><surname>Larance</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multi-Omics analysis of the intermittent fasting response in mice identifies an unexpected role for HNF4α</article-title><source>Cell Reports</source><volume>30</volume><fpage>3566</fpage><lpage>3582</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.051</pub-id><pub-id pub-id-type="pmid">32160557</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>Pu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>QD</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Tchorz</surname><given-names>JS</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair</article-title><source>Science</source><volume>371</volume><elocation-id>eabc4346</elocation-id><pub-id pub-id-type="doi">10.1126/science.abc4346</pub-id><pub-id pub-id-type="pmid">33632818</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Moschetta</surname><given-names>A</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Cummins</surname><given-names>CL</given-names></name><name><surname>McDonald</surname><given-names>JG</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Goodwin</surname><given-names>B</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><name><surname>Gerard</surname><given-names>RD</given-names></name><name><surname>Repa</surname><given-names>JJ</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis</article-title><source>Cell Metabolism</source><volume>2</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2005.09.001</pub-id><pub-id pub-id-type="pmid">16213224</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Anbarchian</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Fish</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>WC</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Wnt signaling regulates hepatocyte cell division by a transcriptional repressor cascade</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2203849119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2203849119</pub-id><pub-id pub-id-type="pmid">35867815</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kind</surname><given-names>T</given-names></name><name><surname>Tsugawa</surname><given-names>H</given-names></name><name><surname>Cajka</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Mehta</surname><given-names>SS</given-names></name><name><surname>Wohlgemuth</surname><given-names>G</given-names></name><name><surname>Barupal</surname><given-names>DK</given-names></name><name><surname>Showalter</surname><given-names>MR</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Fiehn</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of small molecules using accurate mass MS/MS search</article-title><source>Mass Spectrometry Reviews</source><volume>37</volume><fpage>513</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1002/mas.21535</pub-id><pub-id pub-id-type="pmid">28436590</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krizhanovsky</surname><given-names>V</given-names></name><name><surname>Yon</surname><given-names>M</given-names></name><name><surname>Dickins</surname><given-names>RA</given-names></name><name><surname>Hearn</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>J</given-names></name><name><surname>Miething</surname><given-names>C</given-names></name><name><surname>Yee</surname><given-names>H</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Senescence of activated stellate cells limits liver fibrosis</article-title><source>Cell</source><volume>134</volume><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.06.049</pub-id><pub-id pub-id-type="pmid">18724938</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Nascimento</surname><given-names>EM</given-names></name><name><surname>Gajera</surname><given-names>CR</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Neuhöfer</surname><given-names>P</given-names></name><name><surname>Garbuzov</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Artandi</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury</article-title><source>Nature</source><volume>556</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0004-7</pub-id><pub-id pub-id-type="pmid">29618815</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrew</surname><given-names>LL</given-names></name><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Wnt and FGF pathways cooperatively pattern anteroposterior neural ectoderm in <italic>Xenopus</italic></article-title><source>Mechanisms of Development</source><volume>69</volume><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/s0925-4773(97)00160-3</pub-id><pub-id pub-id-type="pmid">9486534</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalopoulos</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Novel insights into liver homeostasis and regeneration</article-title><source>Nature Reviews. Gastroenterology &amp; Hepatology</source><volume>18</volume><fpage>369</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1038/s41575-021-00454-0</pub-id><pub-id pub-id-type="pmid">33911225</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalopoulos</surname><given-names>GK</given-names></name><name><surname>Bhushan</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Liver regeneration: biological and pathological mechanisms and implications</article-title><source>Nature Reviews. Gastroenterology &amp; Hepatology</source><volume>18</volume><fpage>40</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/s41575-020-0342-4</pub-id><pub-id pub-id-type="pmid">32764740</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mihaylova</surname><given-names>MM</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Yilmaz</surname><given-names>ÖH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dietary and metabolic control of stem cell function in physiology and cancer</article-title><source>Stem Cell</source><volume>14</volume><fpage>292</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.02.008</pub-id><pub-id pub-id-type="pmid">24607404</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname><given-names>MD</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent CRE reporter mouse</article-title><source>Genesis</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>LE</given-names></name><name><surname>Soliman</surname><given-names>SS</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Bilder</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Altered modes of stem cell division drive adaptive intestinal growth</article-title><source>Cell</source><volume>147</volume><fpage>603</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.08.048</pub-id><pub-id pub-id-type="pmid">22036568</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>Z</given-names></name><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>de Lima Morais</surname><given-names>DA</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Barrette</surname><given-names>M</given-names></name><name><surname>Gauthier</surname><given-names>C</given-names></name><name><surname>Jacques</surname><given-names>P-É</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>MetaboAnalyst 5.0: narrowing the gap between RAW spectra and functional insights</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>W388</fpage><lpage>W396</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab382</pub-id><pub-id pub-id-type="pmid">34019663</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>WC</given-names></name><name><surname>Logan</surname><given-names>CY</given-names></name><name><surname>Fish</surname><given-names>M</given-names></name><name><surname>Anbarchian</surname><given-names>T</given-names></name><name><surname>Aguisanda</surname><given-names>F</given-names></name><name><surname>Álvarez-Varela</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture</article-title><source>Cell</source><volume>175</volume><fpage>1607</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.012</pub-id><pub-id pub-id-type="pmid">30500539</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perugorria</surname><given-names>MJ</given-names></name><name><surname>Olaizola</surname><given-names>P</given-names></name><name><surname>Labiano</surname><given-names>I</given-names></name><name><surname>Esparza-Baquer</surname><given-names>A</given-names></name><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Marin</surname><given-names>JJG</given-names></name><name><surname>Bujanda</surname><given-names>L</given-names></name><name><surname>Banales</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Wnt-Β-Catenin signalling in liver development, health and disease</article-title><source>Nature Reviews. Gastroenterology &amp; Hepatology</source><volume>16</volume><fpage>121</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/s41575-018-0075-9</pub-id><pub-id pub-id-type="pmid">30451972</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yim</surname><given-names>MJ</given-names></name><name><surname>Swiech</surname><given-names>L</given-names></name><name><surname>Kempton</surname><given-names>HR</given-names></name><name><surname>Dahlman</surname><given-names>JE</given-names></name><name><surname>Parnas</surname><given-names>O</given-names></name><name><surname>Eisenhaure</surname><given-names>TM</given-names></name><name><surname>Jovanovic</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>DB</given-names></name><name><surname>Jhunjhunwala</surname><given-names>S</given-names></name><name><surname>Heidenreich</surname><given-names>M</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Langer</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Crispr-Cas9 knockin mice for genome editing and cancer modeling</article-title><source>Cell</source><volume>159</volume><fpage>440</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.014</pub-id><pub-id pub-id-type="pmid">25263330</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potthoff</surname><given-names>MJ</given-names></name><name><surname>Boney-Montoya</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Sunny</surname><given-names>NE</given-names></name><name><surname>Satapati</surname><given-names>S</given-names></name><name><surname>Suino-Powell</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name><name><surname>Gerard</surname><given-names>RD</given-names></name><name><surname>Finck</surname><given-names>BN</given-names></name><name><surname>Burgess</surname><given-names>SC</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway</article-title><source>Cell Metabolism</source><volume>13</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.03.019</pub-id><pub-id pub-id-type="pmid">21641554</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potthoff</surname><given-names>MJ</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endocrine fibroblast growth factors 15/19 and 21: from feast to famine</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>312</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1101/gad.184788.111</pub-id><pub-id pub-id-type="pmid">22302876</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansone</surname><given-names>SA</given-names></name><name><surname>Fan</surname><given-names>T</given-names></name><name><surname>Goodacre</surname><given-names>R</given-names></name><name><surname>Griffin</surname><given-names>JL</given-names></name><name><surname>Hardy</surname><given-names>NW</given-names></name><name><surname>Kaddurah-Daouk</surname><given-names>R</given-names></name><name><surname>Kristal</surname><given-names>BS</given-names></name><name><surname>Lindon</surname><given-names>J</given-names></name><name><surname>Mendes</surname><given-names>P</given-names></name><name><surname>Morrison</surname><given-names>N</given-names></name><name><surname>Nikolau</surname><given-names>B</given-names></name><name><surname>Robertson</surname><given-names>D</given-names></name><name><surname>Sumner</surname><given-names>LW</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><name><surname>van der Werf</surname><given-names>M</given-names></name><name><surname>van Ommen</surname><given-names>B</given-names></name><name><surname>Fiehn</surname><given-names>O</given-names></name><collab>MSI Board Members</collab></person-group><year iso-8601-date="2007">2007</year><article-title>The metabolomics standards initiative</article-title><source>Nature Biotechnology</source><volume>25</volume><fpage>846</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1038/nbt0807-846b</pub-id><pub-id pub-id-type="pmid">17687353</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>van der Flier</surname><given-names>LG</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Kroon-Veenboer</surname><given-names>C</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Klein</surname><given-names>AM</given-names></name><name><surname>van Rheenen</surname><given-names>J</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Intestinal crypt homeostasis results from neutral competition between symmetrically dividing LGR5 stem cells</article-title><source>Cell</source><volume>143</volume><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.09.016</pub-id><pub-id pub-id-type="pmid">20887898</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Sekiya</surname><given-names>S</given-names></name><name><surname>Büscher</surname><given-names>D</given-names></name><name><surname>Izpisúa Belmonte</surname><given-names>JC</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19arf expression</article-title><source>Development</source><volume>135</volume><fpage>1589</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1242/dev.016634</pub-id><pub-id pub-id-type="pmid">18356246</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Berge</surname><given-names>D</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development</article-title><source>Development</source><volume>135</volume><fpage>3247</fpage><lpage>3257</lpage><pub-id pub-id-type="doi">10.1242/dev.023176</pub-id><pub-id pub-id-type="pmid">18776145</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsugawa</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Uchino</surname><given-names>H</given-names></name><name><surname>Okahashi</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Tada</surname><given-names>I</given-names></name><name><surname>Bonini</surname><given-names>P</given-names></name><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Okazaki</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Z-J</given-names></name><name><surname>Koelmel</surname><given-names>J</given-names></name><name><surname>Cajka</surname><given-names>T</given-names></name><name><surname>Fiehn</surname><given-names>O</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A lipidome atlas in MS-DIAL 4</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>1159</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0531-2</pub-id><pub-id pub-id-type="pmid">32541957</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumbar</surname><given-names>T</given-names></name><name><surname>Guasch</surname><given-names>G</given-names></name><name><surname>Greco</surname><given-names>V</given-names></name><name><surname>Blanpain</surname><given-names>C</given-names></name><name><surname>Lowry</surname><given-names>WE</given-names></name><name><surname>Rendl</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Defining the epithelial stem cell niche in skin</article-title><source>Science</source><volume>303</volume><fpage>359</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1126/science.1092436</pub-id><pub-id pub-id-type="pmid">14671312</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uriarte</surname><given-names>I</given-names></name><name><surname>Fernandez-Barrena</surname><given-names>MG</given-names></name><name><surname>Monte</surname><given-names>MJ</given-names></name><name><surname>Latasa</surname><given-names>MU</given-names></name><name><surname>Chang</surname><given-names>HCY</given-names></name><name><surname>Carotti</surname><given-names>S</given-names></name><name><surname>Vespasiani-Gentilucci</surname><given-names>U</given-names></name><name><surname>Morini</surname><given-names>S</given-names></name><name><surname>Vicente</surname><given-names>E</given-names></name><name><surname>Concepcion</surname><given-names>AR</given-names></name><name><surname>Medina</surname><given-names>JF</given-names></name><name><surname>Marin</surname><given-names>JJG</given-names></name><name><surname>Berasain</surname><given-names>C</given-names></name><name><surname>Prieto</surname><given-names>J</given-names></name><name><surname>Avila</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice</article-title><source>Gut</source><volume>62</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-302945</pub-id><pub-id pub-id-type="pmid">23292666</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>A</given-names></name><name><surname>Kirsch</surname><given-names>DG</given-names></name><name><surname>McLaughlin</surname><given-names>ME</given-names></name><name><surname>Tuveson</surname><given-names>DA</given-names></name><name><surname>Grimm</surname><given-names>J</given-names></name><name><surname>Lintault</surname><given-names>L</given-names></name><name><surname>Newman</surname><given-names>J</given-names></name><name><surname>Reczek</surname><given-names>EE</given-names></name><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Jacks</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Restoration of p53 function leads to tumour regression in vivo</article-title><source>Nature</source><volume>445</volume><fpage>661</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/nature05541</pub-id><pub-id pub-id-type="pmid">17251932</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Fish</surname><given-names>M</given-names></name><name><surname>Logan</surname><given-names>CY</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Self-Renewing diploid AXIN2 (+) cells fuel homeostatic renewal of the liver</article-title><source>Nature</source><volume>524</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1038/nature14863</pub-id><pub-id pub-id-type="pmid">26245375</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>YG</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>Y-H</given-names></name><name><surname>Hsieh</surname><given-names>M-H</given-names></name><name><surname>Albrecht</surname><given-names>JH</given-names></name><name><surname>Le</surname><given-names>PT</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Liver homeostasis is maintained by midlobular zone 2 hepatocytes</article-title><source>Science</source><volume>371</volume><elocation-id>eabb1625</elocation-id><pub-id pub-id-type="doi">10.1126/science.abb1625</pub-id><pub-id pub-id-type="pmid">33632817</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>ÖH</given-names></name><name><surname>Katajisto</surname><given-names>P</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name><name><surname>Gültekin</surname><given-names>Y</given-names></name><name><surname>Bauer-Rowe</surname><given-names>KE</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Birsoy</surname><given-names>K</given-names></name><name><surname>Dursun</surname><given-names>A</given-names></name><name><surname>Yilmaz</surname><given-names>VO</given-names></name><name><surname>Selig</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>GP</given-names></name><name><surname>Mino-Kenudson</surname><given-names>M</given-names></name><name><surname>Zukerberg</surname><given-names>LR</given-names></name><name><surname>Bhan</surname><given-names>AK</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mtorc1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake</article-title><source>Nature</source><volume>486</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nature11163</pub-id><pub-id pub-id-type="pmid">22722868</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H-MI</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name><name><surname>Hsu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Impaired neural development caused by inducible expression of Axin in transgenic mice</article-title><source>Mechanisms of Development</source><volume>124</volume><fpage>146</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2006.10.002</pub-id><pub-id pub-id-type="pmid">17123792</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Fgf15</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom"><italic>BC021328 cloneID 5066286</italic></td><td align="left" valign="bottom">Male</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>C57BL/6</italic> J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 000664 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Rosa26-CreERT2</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 008463 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:00846">IMSR_JAX:00846</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Rosa26-Confetti</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 017492 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:008463">IMSR_JAX:008463</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom">Axin2-rtTA</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 016997 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:016997">IMSR_JAX:016997</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom">TetO-H2B-GFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 005104 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX">IMSR_JAX</ext-link>: 005104</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom">TetO-Cre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat#006234 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006234">IMSR_JAX:006234</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Rosa26-mTmG</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 037456 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX">IMSR_JAX</ext-link>: 037456</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Rosa26-Cas9</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Cat# 026179 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX">IMSR_JAX</ext-link>: 026179</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Tbx3 flox</italic></td><td align="left" valign="bottom">Dr. Anne Moon</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, male</italic>)</td><td align="left" valign="bottom"><italic>Klb</italic> flox</td><td align="left" valign="bottom">Dr. David Mangelsdorf</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab13970 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_300798">AB_300798</ext-link></td><td align="char" char="." valign="bottom">1:500 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-RFP (Rabbit polyclonal)</td><td align="left" valign="bottom">Rockland</td><td align="left" valign="bottom">Cat# 600-401-379 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2209751">AB_2209751</ext-link></td><td align="char" char="." valign="bottom">1:500 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Hnf4 (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab41898 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_732976">AB_732976</ext-link></td><td align="left" valign="bottom">1:500 IF; 50 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Klotho (Rat monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Klotho KL-115 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2618099">AB_2618099</ext-link></td><td align="char" char="." valign="bottom">1:50 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-FGF15 (Mouse monoclonal, IgG2a)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-514647 RRID NA</td><td align="char" char="." valign="bottom">1:50 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Phospho-Tryosine (mouse monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9411 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331228">AB_331228</ext-link></td><td align="char" char="." valign="bottom">1:50 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Phospho-c-Jun (Ser73) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 3270, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2129575">AB_2129575</ext-link></td><td align="char" char="." valign="bottom">1:50 IF</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Tbx3 (Goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-17871 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_661666">AB_661666</ext-link></td><td align="char" char="." valign="bottom">1:50 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Goat IgG (Donkey <break/>polyclonal)</td><td align="left" valign="bottom">Jackson Immuno <break/>Research Labs</td><td align="left" valign="bottom">Cat# 705-065-147 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340397">AB_2340397</ext-link></td><td align="char" char="." valign="bottom">1:200 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Glutamine Synthetase (Mouse monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# MAB302 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2110656">AB_2110656</ext-link></td><td align="char" char="." valign="bottom">1:500 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Catenin, beta (mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 610154 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_397555">AB_397555</ext-link></td><td align="char" char="." valign="bottom">1:50 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Hnf4 (Rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-8987 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2116913">AB_2116913</ext-link></td><td align="char" char="." valign="bottom">1:50 IHC</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">KI67(SolA15) (Rat, monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 14-5698-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10854564">AB_10854564</ext-link></td><td align="char" char="." valign="bottom">1:50 IHC</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pAAV-Guide-it-Down</td><td align="left" valign="bottom"><italic>Clontech Laboratories Inc</italic>.</td><td align="left" valign="bottom">Cat# <italic>041315</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pscAAV-TTR-mFgf15</td><td align="left" valign="bottom">This paper and Addgene</td><td align="left" valign="bottom">Currently Deposit 81516</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">sgAPC_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Assembly primers for <break/>pAAV-Guide-it-Down targeting</td><td align="left" valign="bottom"><italic><named-content content-type="sequence">CCGGAGGCTGCATGAGAGCACTTG3</named-content></italic></td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">sgAPC_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Assembly primers for <break/>pAAV-Guide-it-Down targeting</td><td align="left" valign="bottom"><italic><named-content content-type="sequence">AAACCAAGTGCTCTCATGCAGCCT3</named-content></italic></td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">sgRNA: targeting Apc</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Targeting sequence</td><td align="left" valign="bottom"><italic><named-content content-type="sequence">AGGCTGCATGAGAGCACTTG</named-content></italic></td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">In-Fusion HD Cloning</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Cat# 639647</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">RNAscope probe-Mm-Cyp2f2</td><td align="left" valign="bottom">Advanced Cell Diagnostics</td><td align="left" valign="bottom">Cat# 451851</td><td align="left" valign="bottom">target region: 555–169</td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">RNAscope probe-Mm-Cyp2e1-C2</td><td align="left" valign="bottom">Advanced Cell Diagnostics</td><td align="left" valign="bottom">Cat# 402781 C2</td><td align="left" valign="bottom">target region: 458–1530</td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">RNeasy Mini Isolation Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Cat# 74004</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">High Capacity cDNA Reverse Transcription Kit</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat# 4368814</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Taqman Gene Expression Assay (<italic>Gapdh</italic>)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# 4331182; Mm99999915_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Expression Assay (<italic>Klb</italic>)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# 4331182; Mm00473122_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Expression Assay (<italic>Fgf15</italic>)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# 4331182; Mm00433278_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Expression Assay (<italic>Tbx3</italic>)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# 4331182; Mm01195719_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Chromium Single <break/>Cell 3” Reagents Kit V3</td><td align="left" valign="bottom">10 x Genomics</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Discontinued</td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">NovaSeq S2 v.1.5 Reagent Kits</td><td align="left" valign="bottom">Illumnina</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Discontinued</td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Filter Microplates</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">Cat#203980–100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Tamoxifen</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">Cat# T5648-1G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Doxycycline hyclate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# D9891</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">HistoClear</td><td align="left" valign="bottom">Natural Diagnostics</td><td align="left" valign="bottom">Cat# HS2001GLL</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Antigen Unmasking Solution, <break/>Tris-Based</td><td align="left" valign="bottom">Vector Labs</td><td align="left" valign="bottom">Cat# H-3301</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Avidin/Biotin Blocking Kit</td><td align="left" valign="bottom">Vector Labs</td><td align="left" valign="bottom">Cat# SP-2001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Click-iT Plus TUNEL Assay <break/>Kits for In Situ Apoptosis <break/>Detection</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# C10619</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">FxCycle PI/RNase</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# F10797</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">TRIzol Reagent</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 15596026</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH <ext-link ext-link-type="uri" xlink:href="https://imagej.net/">https://imagej.net/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 5.0 software</td><td align="left" valign="bottom">GraphPad Software; <break/><ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom"><italic>Cell Ranger Software <break/>(v3.1.0, mm10 ref genome</italic>)</td><td align="left" valign="bottom">10 x Genomics Software; <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017344">SCR_017344</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom"><italic>Seraut Software (v3.0, R package</italic>)</td><td align="left" valign="bottom">Seurat Software; <ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/get_started.htm">https://satijalab.org/seurat/get_started.htm</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016341">SCR_016341</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">BD FACS Diva 8.0 software (BD)</td><td align="left" valign="bottom">BD FACS Diva software; <break/><ext-link ext-link-type="uri" xlink:href="http://www.bdbiosciences.com/instruments/software/facsdiva/index.jsp">http://www.bdbiosciences.com/instruments/software/facsdiva/index.jsp</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001456">SCR_001456</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">MS-DIAL v4.60 software</td><td align="left" valign="bottom">MS-DIAL software; (<xref ref-type="bibr" rid="bib34">Tsugawa et al., 2020</xref>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">MetaboAnalyst 5.0 software</td><td align="left" valign="bottom">MetaboAnalyst software; <ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/">https://www.metaboanalyst.ca/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015539">SCR_015539</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">AAV/DJ8-Ttr-Cre</td><td align="left" valign="bottom"><italic>Vector Bio Labs</italic></td><td align="char" char="." valign="bottom">7102</td><td align="left" valign="bottom">AAV-DJ8 virus that expresses an <break/>improved Cre under a liver-specific <break/>Ttr promoter</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">AAV8-Null</td><td align="left" valign="bottom"><italic>Vector Bio Labs</italic></td><td align="char" char="." valign="bottom"><bold>7077</bold></td><td align="left" valign="bottom">AAV serotype 8 virus that has a <break/>CMV promoter with no transgene. <break/>It's used as control AAV in the paper.</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82311.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mistry</surname><given-names>Pramod</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.10.16.464650" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.10.16.464650"/></front-stub><body><p>This work reports that intermittent fasting alters the homeostatic regenerative programme with fundamental implications for the use of murine models to study liver regeneration and cancer and highlights through a series of solid mechanistic studies the role of FGF/Wnt signalling interactions in modulating fasted-associated regeneration. It opens up further questions as to why this occurs, how this is beneficial to adapting to a fasting state and how we should design and interpret preclinical animal studies.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82311.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mistry</surname><given-names>Pramod</given-names></name><role>Reviewing Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Mistry</surname><given-names>Pramod</given-names></name><role>Reviewer</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Bird</surname><given-names>Tom</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01nrxwf90</institution-id><institution>University of Edinburgh</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.10.16.464650">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.10.16.464650v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Intermittent fasting induces rapid hepatocyte proliferation to restore the hepatostat in the mouse liver&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, including Pramod Mistry as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Mone Zaidi as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Tom Bird (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>This is an interesting and highly provocative report opening up a variety of questions relating to how we interpret mouse models in the context of their environment, here relating to feeding, in comparison to human physiology and pathophysiology. Overall, the authors are to be congratulated on this important body of work comprising a series of well-designed, rigorously performed, and appropriately analyzed experiments. The conclusions on the whole are strongly supported by the data presented. The fundamental question is topical and the results provocative.</p><p>Recommendations:</p><p>1. Regarding the conclusions on the timescale of proliferation relative to refeeding. The analysis in Figure 1 is taken 30 minutes following refeeding and this hyperproliferation is then related to FGF15 transcription in the intestine. Can the authors comment on how they reconcile the time frame of induction given their data? Is there downregulation of the downstream pathway over the same time course of FGF15 transcription in the intestine for example? Recommend nuance in the conclusions in the abstract to take account of the lack of direct evidence for intestinally derived FGF15.</p><p>2. The FGF/Wnt-Bcatenin interaction is compelling and shown robustly. Additional characterization of the APC model would be helpful, specifically a statement of whether those clones only outwith the physiological GS areas were quantified, whether these clones also express Tbx3 (and/or other Bcatenin targets) as would be anticipated and show relative hyperproliferation (measured by Ki67/BrdU) compared to other hepatocytes. It would also be helpful to test whether the IF status affects the baseline Wnt/Bcat signature across the liver lobule, either dependent or independent of FGF signaling via Klb. The pseudobulk transcriptomic data presented in Supplementary Figure 2 goes some way to reassuring that there is no such effect on zonal Wnt signatures but this would be further supported by quantified IHC data examining specific B-cat targets e.g. GS/OAT etc.</p><p>3. It is notable that the proliferation at 1-3 weeks IF is towards the inner border of GS-expressing hepatocytes. Do the authors know the relative expression of Tbx3 in these hepatocytes and do they have data to suggest that altered, specifically higher, levels of Tbx3 in the immediately pericentral hepatocytes may relatively impair proliferation – was this dependent on FGF levels for example in the AAV overexpression system?</p><p>4. Suggest caution in the use of Mann-Whitney tests to compare multiple comparisons of integer data (clonal size). A statistical comparison of the data in Supplementary Figure 2 would be welcomed.</p><p>5. Please note that the 3-week control IF data in Figures 4A and B are conflicting. Are the authors confident that the biological sample size is sufficient to demonstrate statistically valid interpretation from their depletion studies?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is an interesting and highly provocative report opening up a variety of questions relating to how we interpret mouse models in the context of their environment, here relating to feeding, in comparison to human physiology and pathophysiology. Overall, the authors are to be congratulated on this important body of work compromising a series of well-designed, rigorously performed, and appropriately analysed experiments. The conclusions on the whole are strongly supported by the data presented. The fundamental question is topical and the results provocative.</p><p>My single largest concern regarding the conclusions drawn from the data presented is in relation to the timescale of proliferation relative to refeeding. The analysis in Figure 1 is taken 30 minutes following refeeding and this hyperproliferation is then related to FGF15 transcription in the intestine. This does not definitely prove that intestinally derived FGF15 is driving this proliferation. Secondly, regarding this temporal relationship, it seems remarkable to me that the appearance of transcript in the intestine would, within a matter of minutes, result in the endocrine induction of proliferation (Ki67 expression) in another organ. Can the authors comment on how they reconcile the time frame of induction given their data? Is there downregulation of the downstream pathway over the same time course of FGF15 transcription in the intestine for example? I do not feel that an intestinal knockout is required, but would recommend nuancing the conclusions in the abstract to take account of the lack of direct evidence for intestinally derived FGF15.</p><p>The FGF/Wnt-Bcatenin interaction and compelling and shown robustly. Additional characterisation of the APC model would be helpful, specifically a statement of whether those clones only outwith the physiological GS areas were quantified, whether these clones also express Tbx3 (and/or other Bcatenin targets) as would be anticipated and show relative hyperproliferation (measured by Ki67/BrdU) compared to other hepatocytes. It would also be helpful to test whether the IF status affects the baseline Wnt/Bcat signature across the liver lobule, either dependent or independent of FGF signaling via Klb. The pseudobulk transcriptomic data presented in Supplementary Figure 2 goes some way to reassuring that there is no such effect on zonal Wnt signatures but this would be further supported by quantified IHC data examining specific B-cat targets e.g. GS/OAT etc.</p><p>It is notable that the proliferation at 1-3 weeks IF is towards the inner border of GS-expressing hepatocytes. Do the authors know the relative expression of Tbx3 in these hepatocytes and do they have data to suggest that altered, specifically higher, levels of Tbx3 in the immediately pericentral hepatocytes may relatively impair proliferation – was this dependent on FGF levels for example in the AAV overexpression system?</p><p>I would caution against the use of Mann-Whitney tests to compare multiple comparisons of integer data (clonal size).</p><p>Statistical comparison of the data in Supplementary Figure 2 would be welcomed.</p><p>I would note that the 3-week control IF data in Figures 4A and B are conflicting. Are the authors confident that the biological sample size is sufficient to demonstrate statistically valid interpretation from their depletion studies?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82311.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Recommendations:</p><p>1. Regarding the conclusions on the timescale of proliferation relative to refeeding. The analysis in Figure 1 is taken 30 minutes following refeeding and this hyperproliferation is then related to FGF15 transcription in the intestine. Can the authors comment on how they reconcile the time frame of induction given their data? Is there downregulation of the downstream pathway over the same time course of FGF15 transcription in the intestine for example? Recommend nuance in the conclusions in the abstract to take account of the lack of direct evidence for intestinally derived FGF15.</p></disp-quote><p>We thank the reviewers for this feedback. We observed a significant increase in hepatocyte proliferation, by Ki67+ expression, 30 mins after re-feeding in 1-week IF treated animals, compared to AL treated animals and other IF timepoints. During these same time frames, we observed a corresponding peak in Fgf15 expression in the intestine and activation of FGF15-bKLOTHO signaling in the liver at 30 mins post re-feeding.</p><p>We agree with reviewers that although our experiments provide direct, functional evidence that liver FGF15-bKLOTHO signaling regulates hepatocyte proliferation, our results connecting intestinal-produced FGF15 and hepatocyte proliferation are descriptive. We therefore have taken the reviewers recommendations and adjusted the conclusions in the manuscript abstract and results. We hope that future studies will unveil if there is inter-organ, intestine-liver regulation of hepatocyte proliferation during IF.</p><disp-quote content-type="editor-comment"><p>2. The FGF/Wnt-Bcatenin interaction is compelling and shown robustly. Additional characterization of the APC model would be helpful, specifically a statement of whether those clones only outwith the physiological GS areas were quantified, whether these clones also express Tbx3 (and/or other Bcatenin targets) as would be anticipated and show relative hyperproliferation (measured by Ki67/BrdU) compared to other hepatocytes.</p></disp-quote><p>We thank the reviewers for asking for this important clarification. Indeed, only GS+ Apc mutant clones that had discrete boundaries from physiological GS+ pericentral cells were quantified in Figure 3A. Boundaries were determined by having one or more GS negative hepatocytes between the GS+ Apc mutant clone and physiological GS+ pericentral cells. We have clarified this in the methods section of the manuscript.</p><p>Evidence demonstrating that non-pericentral GS+ cells are Tbx3+ in the AAV-U6-sgAPC model has been described in a previous manuscript from our group (Jin et al. 2022). Evidence demonstrating Apc mutated GS+ hepatocytes are hyperproliferative compared to other hepatocytes has been described in (Benhamouche et al., 2006). Our work here has focused on comparing the clonal expansion of Apc mutant cells in the context of IF vs AL. We find that clonal expansion is enhanced with IF (Figure 3A).</p><disp-quote content-type="editor-comment"><p>It would also be helpful to test whether the IF status affects the baseline Wnt/Bcat signature across the liver lobule, either dependent or independent of FGF signaling via Klb. The pseudobulk transcriptomic data presented in Supplementary Figure 2 goes some way to reassuring that there is no such effect on zonal Wnt signatures but this would be further supported by quantified IHC data examining specific B-cat targets e.g. GS/OAT etc.</p></disp-quote><p>To address the reviewer’s request, we have included <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> expression analyses of Axin2, a robust downstream target of Wnt signaling, to demonstrate the impact that 1 week IF treatment has on baseline Wnt/Bcat signaling. We did not observe a baseline change in Axin2 expression between feeding regimens, AL vs. IF, nor a change in lobule distribution of Axin2 (data not shown). We also did not observe a change in Axin2 expression in the presence or absence of liver Klb/Fgf15 signaling.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82311-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>3. It is notable that the proliferation at 1-3 weeks IF is towards the inner border of GS-expressing hepatocytes. Do the authors know the relative expression of Tbx3 in these hepatocytes and do they have data to suggest that altered, specifically higher, levels of Tbx3 in the immediately pericentral hepatocytes may relatively impair proliferation – was this dependent on FGF levels for example in the AAV overexpression system?</p></disp-quote><p>We thank the reviewers for this comment. The reviewers’ hypothesis that hepatocytes with higher levels of Tbx3 may have impaired proliferation, rather than enhanced proliferation, is an intriguing one. Understanding the impact of Tbx3 levels/dosage on hepatocyte proliferative is of great interest. Previous studies using in vitro experiments have demonstrated that higher levels of Tbx3 lead to greater repression of cell cycle inhibitors and consequential enhancement of cell proliferation (Khan et al., 2020; Jin et al., 2022). However, previous studies in the liver have indicated that GS+ hepatocytes, hepatocytes known to have the highest Tbx3 expression across the liver lobule, are less proliferative during AL feeding conditions than other hepatocytes (Wei et al., 2021; He et al., 2021).This suggests that perhaps there are other regulators, besides Tbx3, in GS+ cells that are anti-proliferative and that these regulators may also be impacted by IF treatment. What these regulators are and how they repress hepatocyte proliferation remains an important question for future studies.</p><disp-quote content-type="editor-comment"><p>4. Suggest caution in the use of Mann-Whitney tests to compare multiple comparisons of integer data (clonal size). A statistical comparison of the data in Supplementary Figure 2 would be welcomed.</p></disp-quote><p>As the reviewers suggested, we have replaced the Mann-Whitney test with 1-way ANOVA in Supplementary Figure 2.</p><disp-quote content-type="editor-comment"><p>5. Please note that the 3-week control IF data in Figures 4A and B are conflicting. Are the authors confident that the biological sample size is sufficient to demonstrate statistically valid interpretation from their depletion studies?</p></disp-quote><p>We thank the reviewer for observing this. We calculated % Liver to Body Weight for Figure 4A and Figure 4B using an N=7 and N=5, respectively. We believe the differences in precents among these two distinct experiments may have to do with mouse background. Figure 4A was performed on C57/Blk6 male mice. Figure 4B was performed on littermates from Klb KO; Tbx3 KO animals.</p></body></sub-article></article>